NAMI
ARQT icon

Nomura Asset Management International’s Arcutis Biotherapeutics ARQT Stock Holding History

Nomura Asset Management International’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.5M Sell
95,197
-3,650
-4% -$85K ﹤0.01% 1020
2026
Q1 		$2.33M Buy
+98,847
New +$2.52M ﹤0.01% 944

Other funds holding ARQT

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Nomura Asset Management International's ARQT Position: Q2 2026 in Review

Nomura Asset Management International reduced its Arcutis Biotherapeutics (ARQT) stake by 3.7% in Q2 2026, selling an estimated $85K and leaving 95,197 shares worth $2.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1020.

Nomura Asset Management International first reported a position in ARQT in Q1 2026 and has held it in 2 quarters since. 272 funds tracked by Wall St. Rank hold ARQT as of Q2 2026.

  • Nomura Asset Management International held 95,197 shares of Arcutis Biotherapeutics worth $2.5M as of Q2 2026.
  • Nomura Asset Management International sold 3,650 Arcutis Biotherapeutics shares in Q2 2026, an estimated $85K.
  • Arcutis Biotherapeutics made up ﹤0.01% of Nomura Asset Management International's portfolio in Q2 2026, its #1020 holding.
  • Nomura Asset Management International first reported a position in Arcutis Biotherapeutics in Q1 2026 and has held it in 2 quarters since.
  • 272 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.